MET409, A SUSTAINED FXR AGONIST, DECREASED HEPATIC FAT AND IMPROVED LIVER FUNCTION WITHOUT RAISING LDL-C AFTER 28 DAYS IN NASH PATIENTS

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Harrison, SA; Bashir, M; Shim-Lopez, J; Song, K; Chen, H

Published Date

  • October 1, 2019

Published In

Volume / Issue

  • 70 /

Start / End Page

  • 1257A - 1257A

Published By

Pages

  • 1

Electronic International Standard Serial Number (EISSN)

  • 1527-3350

International Standard Serial Number (ISSN)

  • 0270-9139

Conference Name

  • Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting

Conference Location

  • Boston, MA

Conference Start Date

  • November 8, 2019

Conference End Date

  • November 12, 2019